BIOSYNTHESIS, CHARACTERIZATION, BACTERICIDAL AND TOXIC EFFECT OF SILVER NANOPARTICLES USING Klebsiella pneumoniae STRAIN STC1
Abstract
Nanotechnology dealt with nanoparticles having a size of 1-100nm used significantly in pharmaceutical science and many other fields. The use of microorganisms in the synthesis of nanoparticles emerged as an eco-friendly method. Klebsiella pneumoniae strain STC1 was isolated from cow’s milk and identified by 16S rRNA sequencing. The biosynthesis was done using the fixed ratio of aqueous solution of the bacterial supernatant and AgNO3 and the colour change was observed which proved the formation of silver nanoparticles. The nanoparticles were characterized by UV-Visible Spectrophotometer, FTIR, XRD and SEM. The nanoparticles were found to have sizes ranging from 15 to 70nm. The antibacterial activity of silver nanoparticles was studied against methicillin resistant Staphylococcus aureus, Clostridium perfringens, Pseudomonas sp. and Proteus sp. The Minimum Inhibitory Concentration of silver nanoparticles was found to be 50µg/ml against methicillin resistant Staphylococcus aureus. The synergistic effect of the silver nanoparticles with commercial antibiotics erythromycin and tetracycline was found to be more evident. The time kill assay and the cytoplasm diffusion assay showed the effectiveness of synthesized silver nanoparticles in the study. The synthesized silver nanoparticles had a great antibacterial potential against methicillin resistant Staphylococcus aureus. The toxic effect of silver nanoparticles revealed that as the concentration of the silver nanoparticles increased, the effect of toxicity increased and the hatching percentage of Artemia cysts decreased. The innovation in this present study is that the biosynthesis of nanoparticles is simple, cost effective, providing good bactericidal and cytotoxic activity and it can represent a future for more therapeutic and pharmacological applications.
Keywords:
Silver nanoparticles, Biological Synthesis, Antibacterial, methicillin resistant Staphylococcus aureus, Artemia cysts, toxicityDOI
https://doi.org/10.25004/IJPSDR.2020.120514References
Nephawe MJ. Biosynthesis, characterization and antibacterial activity of silver and gold nanoparticles from the leaf and bark extracts of Zanthoxylum capense. Masters thesis. Univeristy of Johannesburg. 2015.
Al-Thawadi S, Rasool AS, Youssef K. Antimicrobial activity of biosynthesized silver nanoparticles against E. coli and B. subtilis. J. Bioanal. Biomed. 2017; 9:299-305.
Tripathi M, Kumar A, Kumar S. Characterization of silver nanoparticles synthesizing bacteria and its possible use in treatment of Multi drug resistant isolate. Front. Environ. Microbio. 2017; 3(4):62-67.
Bergey's manual of determinative bacteriology (7th ed.). Am J Public Health Nations Health. 1964; 54(3):544.
Yasmeen T, Essa A F, Faisal A, Urooj K S. Temporal expression of extracellular products of Staphylococcus aureus in vivo mouse cage model. J. Pak. Med. Assoc. 2012; 539-45.
Kushwaha A, Singh VK, Bhartariya J, Singh P, Yasmeen K. Isolation and identification of E. coli bacteria for the synthesis of silver nanoparticles: Characterization of the particles and study of antibacterial activity. Eur. J. Exp. Biol. 2015; 5(1):65-70.
Mohammed AE, Al-Qahtani A, al-Mutairi A, Al-Shamri B. Antibacterial and cytotoxic potential of biosynthesized silver nanoparticles by some plant extracts. Nanomaterials. 2018; 8 (382):1-15.
Kumar MA, Jayeeta B, Sanjay K, Banerjee UC. Biosynthesis of silver nanoparticles: Elucidation of prospective mechanism and therapeutic potential. J. Colloid Interface Sci. 2014; 415(1):39-47.
Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomed-Nanotechnol. 2012; 8(6):916-924.
Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966; 45:493-496.
May J, Shannon K, King A, French G. Glycopeptide tolerance in Staphylococcus aureus. J. Antimicrob. Chemother. 1998:42 (2):189-97.
Woods, Washington. (1995). Principles and Practice of Infectious Diseases. 4 ed. Mandell, Bennett, & Dolin, Eds. New York: Churchill Livingstone.
Iroegbu CU, Okoli S. In vitro antibacterial activity of Synclisa scabrida whole root extracts. Afr. J. Biotechnol. 2005; 4(9):946-952.
Sibanda T, Okoh A I. In vitro antibacterial regimes of crude aqueous and acetone ectracts of Garcinia kola seeds. J. Biol. Sci. 2008; (1):149-158.
Cwala Z, Igbinosa EO, Okoh AI. Assessment of antibiotics production potentials in four actinomycetes isolated from aquatic environments of the Eastern Cape Province of South Africa. African Journal of Pharmacy and Pharmacology. 2011; 5(2), 118-124.
Maruthai K, Vallayyachari K, Ravibalan T, Philip SA, Antony, Muthuraj M. Antibacterial activity of the silver nanoparticles against Escherichia coli and Enterobacter sp. Prog.Biosci. Bioeng. 2017; 1(1):29-35.
Perveen S, Naqvi SB, Fatima A. Antimicrobial susceptibility pattern of clinical isolates from cases of ear infection using amoxicillin and cefepime. Springer plus. 2013; 288 (2):1-5.
Tiwari DK., Behari J, Sen P. Time and dose-dependent antimicrobial potential of Ag nanoparticles synthesized by top-down approach. Current science. 2008; 95(5):647-655.
Manivasagan P, Gnanam S, Kannan S, Thangaradjou T, Vijayalakshmi S, Balasubramanian T. Antimicrobial and cytotoxic activities of an Actinobacteria (Streptomyces sp. PM-32) isolated from an offshore sediments of the Bay of Bengal in Tamilnadu. Adv.Biol. Res. 2009; 3 (5-6), 231-236.
Arulvasu C, Jennifer S, Prabhu D, Chandhirasekar D. Toxicity effect of silver nanoparticles in Brine shrimp Artemia. Sci.World J. 2014; 1-11.
Schmid, Riediker. Use of nanoparticles in swiss industry: a targeted survey. Environ. Sci.Technol. 2008; 42(7): 253-2260.
Perugini P, Simeoni S, Scalia S et al. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int. J.Pharm. 2002; 246 (1-2), 37-45.
Kumar A, Kumar S, Kumar P, Arumugam P. Synthesis and characterization of silver nanoparticles using E. coli. BioMedRx. 2013; 4(1):382-385.
Koilparambil D, Kurian L, Vijayan S, Shaikmoideen JM. Green synthesis of silver nanoparticles by Escherichia coli: analysis of antibacterial activity. J. Water and Environ Nanotechnol. 2016; 1(1):63-74.
Kumar N, Das S, Jyoti A, Kaushik S. Synergistic effect of silver nanoparticles with Doxycycline against Klebsiella pneumoniae. Int. J. Pharm. Pharm Sci. 2016; 8(7): 183-186.
Published
Abstract Display: 315 
PDF Downloads: 512 
